PFBT
WGS icon

Parkside Financial Bank & Trust’s GeneDx Holdings WGS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$322 Sell
5
-5
-50% -$456 ﹤0.01% 2614
2025
Q4 		$1.3K Hold
10
– – ﹤0.01% 2251
2025
Q3 		$1.08K Buy
10
+5
+100% +$545 ﹤0.01% 2256
2025
Q2 		$462 Sell
5
-5
-50% -$393 ﹤0.01% 2590
2025
Q1 		$886 Buy
+10
New +$868 ﹤0.01% 2152

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parkside Financial Bank & Trust's WGS Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its GeneDx Holdings (WGS) stake by 50% in Q1 2026, selling an estimated $456 and leaving 5 shares worth $322. The position accounts for ﹤0.01% of the portfolio, ranked #2614.

Parkside Financial Bank & Trust first reported a position in WGS in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.3K in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Parkside Financial Bank & Trust held 5 shares of GeneDx Holdings worth $322 as of Q1 2026.
  • Parkside Financial Bank & Trust sold 5 GeneDx Holdings shares in Q1 2026, an estimated $456.
  • GeneDx Holdings made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2614 holding.
  • Parkside Financial Bank & Trust first reported a position in GeneDx Holdings in Q1 2025 and has held it in 5 quarters since.
  • Parkside Financial Bank & Trust's GeneDx Holdings position peaked at $1.3K in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.